Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Adham S. Bear(California University of Pennsylvania), Beatriz M. Carreno(California University of Pennsylvania)
Cited by 111
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
|Cell|2020|534
EZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models
|Cancer Cell|2025|47
CD5 deletion enhances the antitumor activity of adoptive T cell therapies
|Science Immunology|2024|45